GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » EV-to-Revenue

Lombard Medical Technologies (LSE:LMT) EV-to-Revenue : 21.68 (As of Jun. 07, 2024)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Lombard Medical Technologies's enterprise value is £84.34 Mil. Lombard Medical Technologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2012 was £3.89 Mil. Therefore, Lombard Medical Technologies's EV-to-Revenue for today is 21.68.

The historical rank and industry rank for Lombard Medical Technologies's EV-to-Revenue or its related term are showing as below:

LSE:LMT's EV-to-Revenue is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.055
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-07), Lombard Medical Technologies's stock price is £1.89. Lombard Medical Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2012 was £0.19. Therefore, Lombard Medical Technologies's PS Ratio for today is 9.79.


Lombard Medical Technologies EV-to-Revenue Historical Data

The historical data trend for Lombard Medical Technologies's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies EV-to-Revenue Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 2.84 9.15 4.22 9.07

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lombard Medical Technologies's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lombard Medical Technologies's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's EV-to-Revenue falls into.



Lombard Medical Technologies EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Lombard Medical Technologies's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=84.341/3.89
=21.68

Lombard Medical Technologies's current Enterprise Value is £84.34 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lombard Medical Technologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2012 was £3.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lombard Medical Technologies  (LSE:LMT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Lombard Medical Technologies's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.89/0.193
=9.79

Lombard Medical Technologies's share price for today is £1.89.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2012 was £0.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lombard Medical Technologies EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.